三個皮匠報告
政策庫
new
付費
搜索

AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益-行業數據

圖片屬性
圖片格式：PNG 圖片大?。?98KB 圖片尺寸：2304*1767
同報告圖片
 / 28
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第1頁
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
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第2頁
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
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第3頁
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第4頁
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第5頁
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
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第6頁
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
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第7頁
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
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第8頁
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
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第9頁
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第10頁
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第11頁
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第12頁
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第13頁
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
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第14頁
fCDoja/niannu4TlkIggICAgICAgICAgICAgICB8IE9SUiAoJSkgfCBEQ1IgKCUpIHwKfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tfC0tLS0tLS0tLXwKfCBBSzExMiAoTj0zMjEpICAgICAgICB8IDU2LjMgICAgfCAxMDAuMCAgIHwKfCBQZW1icm9saXp1bWFiIChOPTI2MykgfCA0Mi4zICAgIHwgODQuNiAgICB8CnwgUGVtYnJvbGl6dW1hYiBpbiAoTj02MzcyKSB8IDI3LjMgICAgfCA2NS45ICAgIHwKCui1hOaWmeadpea6kO+8muaKlei1hOiAhea8lOekuuadkOaWme+8jOS4reazsOivgeWIuOeglOeptuaJgO+8jOaVsOaNruaIquiHszIwMjHlubTjgII=
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第15頁
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
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第16頁
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第17頁
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第18頁
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第19頁
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
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第20頁
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第21頁
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第22頁
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第23頁
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第24頁
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第25頁
fCDogqHkuJwgICAgICAgfCDmjIHogqHmr5TkvosgfAp8LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS18Cnwg5aSP55GcICAgICAgIHwgMTUuNyUgICAgfAp8IOWkj+awj+S/oeaJmCAgIHwgNi44NyUgICAgfAp8IOadjuawj+S/oeaJmCAgIHwgNS4wOCUgICAgfAp8IOeOi+awj+S/oeaJmCAgIHwgMS42MyUgICAgfAp8IOWFtuS7luiCoeS4nCAgIHwgNzAuNzIlICAgfAoK6LWE5paZ5p2l5rqQ77ya5ZCM6Iqx6aG677yM5Lit5rOw6K+B5Yi456CU56m25omA
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第26頁
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第27頁
fCDlj4LmlbAgfCBBSzEwNSB8IE5pdm9sdW1hYiB8IFBlbWJyb2xpenVtYWIgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8CnwgS0QgKE0pIHwgNS44OEUtMTAgfCA1LjQwRS0xMCB8IDcuMTdFLTEwIHwKfCBrb24gKDEvTXMpIHwgMS42MkUrMDUgfCA0LjUwRSswNSB8IDMuOTFFKzA1IHwKfCBrZGlzICgxL3MpIHwgOS41MUUtMDUgfCAyLjQzRS0wNCB8IDIuODBFLTA0IHwKfCBSbWF4IChSVSkgfCAzMi41Mi00Ni44MCB8IDMzLjk3LTQ4LjAxIHwgNDQuODQtNjMuOTEgfAoK6LWE5paZ5p2l5rqQ77ya44CKUGVtYnJvbGl6dW1hYiwgYW4gRmMtRW5naW5lZXJlZCBJZ0cxIEFudGktUEQtMSBBbnRpYm9keSwgV2l0aCBJbXByb3ZlZCBFZmZpY2FjeSBhbmQgTG93IEluY2lkZW5jZSBvZiBJbW11bmUtUmVsYXRlZCBBZHZlcnNl44CL
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第28頁
AK104作為免疫療法針對PD-L1低表達一線胃癌亦有優越的長期獲益_第29頁
fCDlk4HniYwgICAgICAgfCDljaDmr5QgIHwKfC0tLS0tLS0tLS0tLXwtLS0tLS18CnwgQkFJIFpFIEFOICB8IDM1JSAgfAp8IFRZVllUICAgICAgfCAyNSUgIHwKfCBBTCBSVUkgS0EgIHwgMTUlICB8CnwgS0VZVFJVREEgICB8IDEwJSAgfAp8IFRVTyBZSSAgICAgfCA1JSAgIHwKfCBIQU4gU0hJIFpIVUFORyB8IDMlICB8CnwgVEVDRU5UUklRICB8IDIlICAgfAp8IE9QRElWTyAgICAgfCAyJSAgIHwKfCBBTiBOSSBLRSAgIHwgMSUgICB8CnwgRU4gV0VJIERBICB8IDElICAgfAp8IE9USEVSUyAgICAgfCAxJSAgIHwKCui1hOaWmeadpea6kO+8mklRVklB77yM5Lit5rOw6K+B5Yi456CU56m25omA
所屬報告： 康方生物-港股公司研究報告-雙特異抗體龍頭國際化之路現勝利曙光-240621（37頁）.pdf
打包全文圖表

相關數據

最新數據
聯系我們
  • 0731-84720580
  • sgpjbg002
  • 工作日 9:30 - 18:00
關于我們
侵權處理
關于我們

三個皮匠報告專業的行業報告下載站，每日更新，歡迎大家關注！

copyright@2008-2013 長沙景略智創信息技術有限公司版權所有
網站備案/許可證號：湘B2-20190120

客服
商務合作
小程序
服務號
折疊
午夜网日韩中文字幕,日韩Av中文字幕久久,亚洲中文字幕在线一区二区,最新中文字幕在线视频网站